STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Penumbra, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Penumbra, Inc. submitted a Form 144 notifying a proposed sale under Rule 144 of 12,000 shares of its common stock through J.P. Morgan Securities LLC. The filing reports an aggregate market value of $2,982,600 for the shares, an approximate sale date of 08/13/2025, and lists the securities exchange as the NYSE. The filing also shows 38,999,129 shares outstanding.

The 12,000 shares were acquired on 06/22/2004 as founder stock from the issuer. The filer reports "Nothing to Report" for securities sold during the past three months and includes the standard representation that the selling person does not know of undisclosed material adverse information about the issuer.

Positive
  • Transparent disclosure of proposed sale details including number of shares, aggregate market value, broker, and approximate sale date
Negative
  • None.

Insights

TL;DR: Routine Form 144 filing for a proposed sale of 12,000 founder shares; disclosure is clear and the position is small versus total outstanding.

The filing documents a proposed sale of 12,000 common shares via J.P. Morgan with an aggregate market value of $2,982,600 and an approximate sale date of 08/13/2025. The shares were acquired as founder stock on 06/22/2004 and the filer reports no sales in the past three months. For investors, this is a transparent disclosure of insider/affiliate selling activity; absent other context, the filing by itself does not indicate operational or financial changes at the company.

TL;DR: This is a compliance-focused disclosure under Rule 144 showing an orderly proposed sale with required representations; no governance red flags are evident in the form.

The Form 144 supplies required details: broker name and address, share count, aggregate market value, acquisition date and nature (founder stock), and a representation about undisclosed material adverse information. The filer also indicates no recent sales to aggregate. From a governance standpoint, the form meets disclosure requirements and does not, on its face, signal regulatory or compliance concerns.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Penumbra (PEN) Form 144 report?

The Form 144 reports a proposed sale of 12,000 shares of common stock with an aggregate market value of $2,982,600 through J.P. Morgan Securities LLC on approximately 08/13/2025.

When and how were the 12,000 shares acquired according to the filing?

The filing states the shares were acquired on 06/22/2004 as founder stock from the issuer.

Are there any reported sales of the issuer's securities by the filer in the past three months?

No. The Form 144 states "Nothing to Report" for securities sold during the past three months.

Which broker and exchange are named in the Form 144?

The broker is J.P. Morgan Securities LLC (390 Madison Avenue, New York, NY) and the exchange listed is the NYSE.

Does the filer make any representations about material information?

Yes. By signing the notice, the person represents they do not know of any undisclosed material adverse information regarding the issuer.
Penumbra Inc

NYSE:PEN

PEN Rankings

PEN Latest News

PEN Latest SEC Filings

PEN Stock Data

10.96B
37.48M
3.66%
93.38%
4.59%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ALAMEDA